AFRICAN SWINE FEVER (ASF)

Passive surveillance of African Swine Fever (ASF) in wild boars as an effective tool for prevention, control and eradication of ASF: A new approach Welz, M., Popczyk, B., Niemczuk, K., (…), Jażdżewski, K., Konopka, B.	2021 Medycyna Weterynaryjna, 77(5), pp. 245-252.

Passive surveillance of African Swine Fever (ASF) in wild boars as an effective tool for prevention, control and eradication of ASF: A new approach Welz, M., Popczyk, B., Niemczuk, K., (…), Jażdżewski, K., Konopka, B. 2021 Medycyna Weterynaryjna, 77(5), pp. 245-252.

Pathogen detection and disease diagnosis in wildlife: challenges and opportunities Michel, A.L., Van Heerden, H., Crossley, B.M., (…), Prasse, D., Rutten, V.	2021	Revue scientifique et technique (International Office of Epizootics), 40(1), pp. 105-118.

Pathogen detection and disease diagnosis in wildlife: challenges and opportunities Michel, A.L., Van Heerden, H., Crossley, B.M., (…), Prasse, D., Rutten, V. 2021 Revue scientifique et technique (International Office of Epizootics), 40(1), pp. 105-118.

A semi-quantitative model for ranking the risk of incursion of exotic animal pathogens into a European Union Member State  Open Access Condoleo, R., Taylor, R.A., Simons, R.R.L., (…), Mezher, Z., Roberts, H. 2021 Microbial Risk Analysis, art. no. 100175.

A semi-quantitative model for ranking the risk of incursion of exotic animal pathogens into a European Union Member State Open Access Condoleo, R., Taylor, R.A., Simons, R.R.L., (…), Mezher, Z., Roberts, H. 2021 Microbial Risk Analysis, art. no. 100175.

New perspectives for evaluating relative risks of African swine fever virus contamination in global feed ingredient supply chains Shurson, G.C., Palowski, A., van de Ligt, J.L.G., (…), Urriola, P.E., Sampedro, F. 2021 Transboundary and Emerging Diseases.

New perspectives for evaluating relative risks of African swine fever virus contamination in global feed ingredient supply chains Shurson, G.C., Palowski, A., van de Ligt, J.L.G., (…), Urriola, P.E., Sampedro, F. 2021 Transboundary and Emerging Diseases.